This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Complications of surgical procedures or medical ca...
  • /
  • Management of infusion reactions to systemic antic...

Management of infusion reactions to systemic anticancer therapy: ESMO Guidelines

Read time: 1 mins
Last updated:30th Jun 2017
Management of Infusion Reactions to Systemic Anticancer Therapy: European Society for Medical Oncology (ESMO) Clinical Practice Guidelines

Most anticancer treatments carry a risk for infusion reactions which incidence may increase when different agents are administered concomitantly. Although infusion reactions can be allergic or non-immune-mediated, the clinical manifestations are the same and require prompt assessment and appropriate intervention. These new ESMO Clinical Practice Guidelines provide tools to evaluate the risk of infusion reactions, to recognise the early signs and symptoms and include recommendations on how to document and manage them.


Read full guideline